Search
for
Sort by
Research 301–330 of 310
- Autolougous platelet concentrates in esthetic medicine
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Pruritic Trichostasis Spinulosa: A Rare Variant
- Phase-specific differential regulation of mechanical allodynia in a murine model of neuropathic pain by progesterone
- Twins with psychiatric features and a nonsense HRAS variant affecting transcript processing
- Neuroendocrine, Neurotransmitter, and Gut Microbiota Imbalance Contributing to Potential Psychiatric Disorder Prevalence in PCOS
- Genome Wide Differential Expression Profiles in Nevus Sebaceous Uncovered Low Expression of CDKN2AIP and Construction of a ceRNA Network
- 612 Wnt signaling induces fibrotic fat loss via DPP4 in skin fibrosis
- Toxic and Metabolic Disorders of the Nervous System
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
- To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application
- Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Side Effects of Medicines Used to Treat Various Somatic Diseases and for Contraception
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Endocrine Aspects of Female Sexual Dysfunction
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE)
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline